Armstrong Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

Armstrong Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$44K	Buy	209 +22	+12%	+$4.41K	﹤0.01%	445
2026 Q2	$35.6K	Hold	187	–	–	﹤0.01%	493
2026 Q1	$31.6K	Hold	187	–	–	﹤0.01%	484
2025 Q4	$31.6K	Hold	187	–	–	﹤0.01%	479
2025 Q3	$27K	Hold	187	–	–	﹤0.01%	506
2025 Q2	$23.7K	Hold	187	–	–	﹤0.01%	511
2025 Q1	$24.7K	Hold	187	–	–	﹤0.01%	477
2024 Q4	$24.7K	Hold	187	–	–	﹤0.01%	477
2024 Q3	$27.2K	Hold	187	–	–	﹤0.01%	456
2024 Q2	$25.7K	Hold	187	–	–	﹤0.01%	453
2024 Q1	$25.4K	Hold	187	–	–	﹤0.01%	440
2023 Q4	$25.4K	Hold	187	–	–	﹤0.01%	440
2023 Q3	$22.9K	Sell	187 -14	-7%	-$1.78K	﹤0.01%	460
2023 Q2	$25.5K	Hold	201	–	–	﹤0.01%	446
2023 Q1	$26K	Hold	201	–	–	﹤0.01%	431
2022 Q4	$26.4K	Buy	+201	New	+$26K	﹤0.01%	432

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Armstrong Advisory Group's IBB Position: Q3 2026 in Review

Armstrong Advisory Group increased its iShares Biotechnology ETF (IBB) stake by 12% in Q3 2026, buying an estimated $4.41K and bringing the position to 209 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Armstrong Advisory Group first reported a position in IBB in Q4 2022 and has held it in 16 quarters since. 213 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Armstrong Advisory Group held 209 shares of iShares Biotechnology ETF worth $44K as of Q3 2026.
Armstrong Advisory Group bought 22 iShares Biotechnology ETF shares in Q3 2026, an estimated $4.41K.
iShares Biotechnology ETF made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #445 holding.
Armstrong Advisory Group first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 16 quarters since.
213 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.